This is in broad agreement with our observation of loss of LXN expression likely by F. nucleatum-associated epigenetic silencing in the HNSCC tumor microenvironment, where bacterial invasion may interfere with the pro-inflammatory immunomodulatory gene signature of LXN in blocking tumor immune cell evasion. Here, LXN is linked to head and neck squamous cell carcinoma.